Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Congress Wants More Answers From J&J On "Phantom Recall"

This article was originally published in The Tan Sheet

Executive Summary

Johnson & Johnson's response to a congressional inquiry regarding the alleged "phantom recall" of a Motrin product left a House committee chairman considering whether to subpoena additional information
Advertisement

Related Content

Consumer Lawsuits Allege J&J Concealed OTC Defects
Consumer Lawsuits Allege J&J Concealed OTC Defects
Consumer Lawsuits Allege J&J Concealed OTC Defects
Congress Hopes To Land J&J Chief Weldon For Second Recall Inquiry
Congress Hopes To Land J&J Chief Weldon For Second Recall Inquiry
Congress Hopes To Land J&J Chief Weldon For Second Recall Inquiry
Towns wants answers on J&J's alleged "phantom recall"
J&J Faces Possible Criminal Liability As Post-Recall Overhaul Continues
McNeil Expands Tylenol Recall As FDA Criticizes Firm's Response To AERs

Topics

Advertisement
UsernamePublicRestriction

Register

PS104198

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel